EUVIMEDEUVIMED entdecken
Crossref

Applying the bioisosterism strategy to obtain lead compounds against SARS‐CoV ‐2 cysteine proteases: An in‐silico approach

João Ricardo Bueno de Morais Borba iD, Leonardo Pereira de Araújo, Marcia Paranho Veloso, Nelson José Freitas da Silveira

Journal of Computational Chemistry · 2024

DOI: 10.1002/jcc.27217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Computational Chemistry, 2024. Verfasst von João Ricardo Bueno de Morais Borba und 3 weiteren Autor:innen. Beteiligte Einrichtung: João Ricardo Bueno de Morais Borba, Laboratory of Molecular Modeling and Computer Simulation - MolMod-CS, Institute of Chemistry, Federal University …. Hauptthemen laut MEDLINE: COVID-19, Cysteine Proteases. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS‐CoV‐2 cysteine proteases are essential nonstructural proteins due to their role in the formation of the virus multiple enzyme replication‐transcription complex. As a result, those functional proteins are extremely relevant targets in the development of a new drug candidate to fight COVID‐19. Based on this fact and guided by the bioisosterism strategy, the present work has selected 126 out of 1050 ligands from DrugBank website. Subsequently, 831 chemical analogs containing bioisosteres, some of which became structurally simplified, were created using the MB‐Isoster software, and molecular docking simulations were performed using AutoDock Vina. Finally, a study of physicochemical properties, along with pharmacokinetic profiles, was carried out through SwissADME and ADMETlab 2.0 platforms. The promising results obtained with the molecules encoded as DB00549_BI_005, DB04868_BI_003, DB11984_BI_002, DB12364_BI_006 and DB12805_BI_004 must be confirmed by molecular dynamics studies, followed by in vitro and in vivo empirical tests that ratify the advocated in‐silico results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Cysteine ProteasesHumansSARS-CoV-2Molecular Docking SimulationProtease InhibitorsCysteine EndopeptidasesMolecular Dynamics Simulation

Stichwörter der Autor:innen

SARS-CoV-2bioisosterismcysteine proteasesmolecular docking

Substanzen

Cysteine ProteasesProtease InhibitorsCysteine Endopeptidases

Autor:innen und Institutionen

  • João Ricardo Bueno de Morais Borba, Laboratory of Molecular Modeling and Computer Simulation - MolMod-CS, Institute of Chemistry, Federal University of Alfenas - UNIFAL-MG, Alfenas, Brazil.
  • Leonardo Pereira de Araújo, Laboratory of Molecular Modeling and Computer Simulation - MolMod-CS, Institute of Chemistry, Federal University of Alfenas - UNIFAL-MG, Alfenas, Brazil.
  • Marcia Paranho Veloso, Laboratory of Molecular Modeling and Computer Simulation - MolMod-CS, Institute of Chemistry, Federal University of Alfenas - UNIFAL-MG, Alfenas, Brazil.
  • Nelson José Freitas da Silveira, Laboratory of Molecular Modeling and Computer Simulation - MolMod-CS, Institute of Chemistry, Federal University of Alfenas - UNIFAL-MG, Alfenas, Brazil.

ORCID-Profile: João Ricardo Bueno de Morais Borba

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Borba, J. R. B. M., de Araújo, L. P., Veloso, M. P., & da Silveira, N. J. F. (2024). Applying the bioisosterism strategy to obtain lead compounds against SARS‐CoV ‐2 cysteine proteases: An in‐silico approach. Journal of Computational Chemistry. https://doi.org/10.1002/jcc.27217

Vancouver

Borba JRBM, de Araújo LP, Veloso MP, da Silveira NJF. Applying the bioisosterism strategy to obtain lead compounds against SARS‐CoV ‐2 cysteine proteases: An in‐silico approach. Journal of Computational Chemistry. 2024. doi:10.1002/jcc.27217

BibTeX
@article{Borba2024,
  author = {Borba, João Ricardo Bueno de Morais and de Araújo, Leonardo Pereira and Veloso, Marcia Paranho and da Silveira, Nelson José Freitas},
  title = {Applying the bioisosterism strategy to obtain lead compounds against SARS‐CoV ‐2 cysteine proteases: An in‐silico approach},
  journal = {Journal of Computational Chemistry},
  year = {2024},
  doi = {10.1002/jcc.27217}
}
Kostenlos starten →